2023
MULTINATIONAL PATTERNS OF SECOND-LINE ANTI-HYPERGLYCEMIC DRUG INITIATION IN ESTABLISHED CARDIOVASCULAR DISEASE: A FEDERATED PHARMACOEPIDEMIOLOGIC EVALUATION IN LEGEND-T2DM
Khera R, Dhingra L, Li K, Aminorroaya A, Zhou J, Arshad F, Bu F, Dorr D, Falconer T, French T, Lau W, Lu Y, Man K, Matheny M, Minty E, Nishimura A, Ostropolets A, Seager S, Y.F. W, Yang J, Yin C, Hripcsak G, Krumholz H. MULTINATIONAL PATTERNS OF SECOND-LINE ANTI-HYPERGLYCEMIC DRUG INITIATION IN ESTABLISHED CARDIOVASCULAR DISEASE: A FEDERATED PHARMACOEPIDEMIOLOGIC EVALUATION IN LEGEND-T2DM. Journal Of The American College Of Cardiology 2023, 81: 1646. DOI: 10.1016/s0735-1097(23)02090-9.Peer-Reviewed Original ResearchDrug initiationDisease
2020
Opium and cardiovascular health: A devil or an angel?
Roayaei P, Aminorroaya A, Vasheghani-Farahani A, Oraii A, Sadeghian S, Poorhosseini H, Masoudkabir F. Opium and cardiovascular health: A devil or an angel? Indian Heart Journal 2020, 72: 482-490. PMID: 33357635, PMCID: PMC7772609, DOI: 10.1016/j.ihj.2020.10.003.Peer-Reviewed Original ResearchConceptsOpium consumptionCardiovascular diseaseEffects of opium consumptionMedical staffChronic diseasesIllicit drug consumptionStable coronary artery diseaseHigher consumptionConsumption of opiumRisk factorsAcute coronary syndromeCoronary artery diseaseAbused substancesTraditional beliefsDiabetes mellitusCoronary syndromeDrug consumptionDiabetic patientsArtery diseaseHealthy individualsAmeliorative effectDiseaseStaffTobacco